MetLife Investment Advisors »

Cg Oncology shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $422k 13k 31.57

More positions owned by MetLife Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Tesla Motors (TSLA)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Visa Inc Class A Com Cl A (V)

View all positions for MetLife Investment Advisors

Top funds holding Cg Oncology

Decheng Capital
TCG Crossover Management
Braidwell
BVF
Vanguard Group
BlackRock
Henderson Group
RA Capital Management
Avidity Partners Management
Franklin Resources
Alliancebernstein
State Street Corporation
Cormorant Asset Management
Frazier Life Sciences Management
Perceptive Advisors

View all funds holding Cg Oncology